Synergistic effect of Ceftriaxone and diclofenac against Escherichia Coli
DOI:
https://doi.org/10.52206/jsmc.2021.11.1.50-55Abstract
Background: The emergence of resistant strains of bacteria has rendered many useful antibiotics ineffective. The researchers are
forced to try combination of two or more antibiotics, or addition of a non- antibacterial to them. Ceftriaxone, a third-generation
cephalosporin agent is used to treat many infectious diseases, especially those caused by members of Enterobacteriaceae family.
We tested the efficacy of ceftriaxone, alone and in combination with various concentrations of diclofenac sodium, against
Escherichia coli.
Objective: To study the synergistic effect of ceftriaxone and its combination with non-antibiotic drug diclofenac sodium against
Escherichia coli ATCC 25922 isolate.
Material and Methods: Agar well diffusion technique was applied. 30 µl of solutions of ceftriaxone, and its combination with
different concentrations of diclofenac sodium and DMSO were transferred aseptically into the wells. Agar plates were placed in incubator at 37°C for 24 hours. Mean zone of inhibition of each drug was calculated.
Results: Ceftriaxone 30µg formed a zone of inhibition of 35 mm. Its combination with 25µg and 50µg of diclofenac sodium formed
zone of inhibition of 37.5mm while its combination with 100µg diclofenac sodium formed a zone of inhibition of 38.6mm and formed
39.8mm zone of inhibition when combined with 200µg diclofenac sodium.
Conclusion: Ceftriaxone activity increased when combined with different concentrations of diclofenac sodium drug showing a
synergistic effect of their combination.
Key words: ceftriaxone, Diclofenac sodium, E. coli, Synergism
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
